Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology.

Martínez-Laperche, CarolinaKwon, MiFranco-Villegas, Ana CChillón, M CarmenCastro, NereaAnguita, EduardoDolz, SandraRodríguez-Medina, CarlosHermosín, LourdesBellón, José MPrieto-Conde, Mª IsabelBarragán, EvaGómez-Casares, MaiteAyala, RosaMartínez-López, JoaquínGonzález-Díaz, MarcosDíez-Martin, José LuisBuño, IsmaelCooperative Group for Molecular Biology in Haematology (GBMH)2023-01-252023-01-252017-04-03http://hdl.handle.net/10668/11043enWilms Tumor 1acute myeloid leukaemiachemotherapyminimal residual diseasestem cell transplantationAdolescentAdultAgedFemaleGene Expression Regulation, LeukemicHumansLeukemia, Myeloid, AcuteMaleMiddle AgedNeoplasm, ResidualRisk AssessmentRisk FactorsSpainWT1 ProteinsWilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology.research article2836977310.1111/bjh.146351365-2141